Bioinformatics Database Bharathidasan University Trichy

1. BIOMED CENTRAL
S. Gayathri
MSFBI1506
1st M.sc Bioinformatics
Bioinformatics Databases

2. BIOMED CENTRAL
 Biomed central is united kingdom based, for
profit scientific publisher specialising in open
access journal publication.
 Biomed central and its sister companies
chemistry central and physmath central
publish over 200 scientific journals.
 Most biomed central describes itself as the
first and largest open access science publisher.
 Its is owned by Springer science + Business
Media.

3. History of Biomed Central
 Biomed central was founded in 2000 as part
of the current science group
 The first director of the company was Jan
Vetterop.
 In 2002, the company’s business model
evolved to include article process charges.

4.  In October 2008, it was announced that
Biomed central had been acquired by spring
science + Business media, the second largest
STM publisher.
In 2007 Yale University libraries stopped
subsiding page charges for affiliates of Yale
whose using Biomed central as the publisher
of their works.
In November 2008 Biomed central became an
official supporting organization of Healthcare
Information.

5. JOURNAL
 Biomed central owns and produces in house
five journals :
i. Genome biologus
ii. Genome medicine
iii. Arthritis Research and Therapy
iv. Breast cancer Research
v. Critical care

6. • It also produces the BMC journal series of 65
journals covering the fields of biology and
medicine.
• Chemistry central journal and Physmath series
of journals are also produces by the company.
• Most of the other journals published by
Biomed central are owned and produced
independently by societies and academic
editorial boards, with Biomed central
providing the hosting publishing platform and
marketing.

7. Home page

8. OPEN ACCESS
 Open access publishing allows free
distribution and access to published articles
 The author retains copyright of their work a
creative commons attribution licence.
 So, all articles are made freely available to the
widest audience possible.
 Biology, medicine, health are the areas
include in biomed central.

10. TIME FOR CHANGING
 Fifteen years ago, the business model for
scientific publishers was to charge users to
view the articles they published.
 This subscription based model for scientific
publishers was to charge users to view the
articles they published.
 Biomed central open access publishing
model changed all that.

11. THE BENEFITS :
The benefits are :
o All articles are free to read, copy, distribute
and use(with attribution).

12. BIOMED CENTRAL THE FIRST OPEN
ACCESS PUBLISHERS
 Part of current science group
 Published first article in mid-2000
 Strict policy of immediate open access
to all research article.

13. PLOS
Public Library of science :
 PLOS is a non-profit publisher and advocacy
organisation founded to accelerate progress in
science and medicine by leading a
transformation in research communication.

14. PEER-REVIWED ARTICLE
 Peer- reviewed(refered or scholarly) journals.
 Articles are written by exports and are
reviewed by several other experts in the field
before the article is published in the field
before to insure the article’s quality.

15. PUBLISHED AND BE FREE
 In a landmark deal more than 80,000 biology and
medicine researches working at UK universities can
now share their research finding freely with fellows
researches post graduates students and the general
public world wide.
 The scheme covers 180 universities and colleges
and researches in the NHS in England.
 The biomed central membership agreement begins
the article processing charges will be waived for all
UK higher education staff when they published in any
of Biomed central’s 90-plus peer reviewed journals
in which all research content is freely accessible.

16. BIOMED CENTRAL JOURNALS ARE
ARCHEIVED IN SEVERAL WAYS :
 On the company’s own servers on
Pubmed central’s serves, through CD-
ROM collections developed by national
libraries through the archive etc.,
 Since the material is available without
registration or subscription search
engines such as Google also index much
of the research material.

17. AIM AND SCOPE
 Unreported or unusual side effects or adverse
interaction involving medications.
 Unexpected or unusual presentations of a
disease
 New associations or variations on disease
process
 Presentations, diagnoses and management of
new and emerging diseases.
 an unexpected association between diseases
or symptoms.

18. Continue…
 An unexpected event in the course of observing
or treating a patients.
 Findings that shed new light on the possible
pathogenesis of a disease or an adverse effect.
 Authors should indicate in the abstract and cover
letter how the case report adds to the medical
literature.
 Submissions that do not indicate this information
be returned to authors prior to peer review.